Nobel Biosciences LLC
Records under this name other than patents Nobel Biosciences LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Nobel Biosciences LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,175,077 | Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) Lapsed on the fee record Ended Nov 3, 2019 · USPTO record | Lapsed on the fee record | Ended Nov 3, 2019 | USPTO record |
| US 7,994,278 | Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) Lapsed on the fee record Ended Aug 9, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 9, 2019 | USPTO record |
| US 6,805,882 | Therapeutic fractions of sources of HCG Term ended Term ended Apr 30, 2018 · USPTO record | Term ended | Term ended Apr 30, 2018 | USPTO record |
| US 6,699,834 | Method for treating cancer Term ended Ended no later than Feb 17, 2018 · USPTO record | Term ended | Ended no later than Feb 17, 2018 | USPTO record |
| US 6,620,416 | Method for treating HIV Term ended Ended no later than Oct 8, 2017 · USPTO record | Term ended | Ended no later than Oct 8, 2017 | USPTO record |
| US 6,583,109 | Therapeutic polypeptides from &bgr;-hCG and derivatives Term ended Ended no later than Jun 24, 2017 · USPTO record | Term ended | Ended no later than Jun 24, 2017 | USPTO record |
| US 6,319,504 | Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin Term ended Term ended Sep 9, 2016 · USPTO record | Term ended | Term ended Sep 9, 2016 | USPTO record |
| US 6,699,656 | Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin Term ended Ended no later than Jun 24, 2016 · USPTO record | Term ended | Ended no later than Jun 24, 2016 | USPTO record |
| US 5,968,513 | Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin Term ended Term ended no later than Oct 19, 2019 · Low confidence | Term ended | Term ended no later than Oct 19, 2019 | Low confidence |
| US 5,997,871 | Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin Term ended Term ended no later than Dec 7, 2019 · Low confidence | Term ended | Term ended no later than Dec 7, 2019 | Low confidence |